Lina Gu

Lina Gu is a Senior Director at Allorion Therapeutics, a biotechnology company focused on developing small molecule therapeutics for cancer and autoimmune diseases.12 She has held this position since September 2021.1

Professional Experience

Lina Gu has an extensive background in the biotechnology industry:

• Allorion Therapeutics: Senior Director (September 2021 - Present)1
• Tango Therapeutics: Director (July 2020 - September 2021) and Associate Director (July 2018 - July 2020)1
• Relay Therapeutics: Biochemist (September 2016 - June 2018)1
• Infinity Pharmaceuticals: Lead Senior Scientist (March 2014 - August 2016) and Senior Scientist (March 2010 - March 2014)1

Education

Lina Gu's educational background includes:

• Ph.D. in Biochemical Engineering from Syracuse University (2000 - 2003)1
• B.E. in Chemical Engineering from Tianjin University (1991 - 1995)1

Expertise

Lina Gu's expertise includes molecular cloning, protein biochemistry, enzymology, and protein crystallography.1 She also completed a postdoctoral fellowship at Harvard Medical School from 2003 to 2007, focusing on protein expression and purification, and X-ray crystallography.1

At Allorion Therapeutics, Lina Gu serves as the head of Biochemistry34, contributing her extensive experience to the company's drug development efforts. Her LinkedIn profile, with the username lina-gu-44b752b, provides a comprehensive overview of her professional journey in the biotechnology sector.1